Acupuncture to Improve Quality of Life in Patients With Advanced Cancer

This study has been completed.
Sponsor:
Information provided by:
National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:
NCT00070967
First received: October 9, 2003
Last updated: August 17, 2006
Last verified: July 2006

October 9, 2003
August 17, 2006
September 2001
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00070967 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Acupuncture to Improve Quality of Life in Patients With Advanced Cancer
Effects of Acupuncture on Pain, Nausea, Quality of Life

This study will test the feasibility of acupuncture as a complementary therapy for advanced cancer by comparing symptoms and quality of life before and after 8 weeks of acupuncture treatments.

A large percentage of the practice and use of complementary and alternative medicine (CAM) in the United States is focused on cancer. Whether the CAM use is aimed at reducing one's risk of developing cancer or improving the quality of life of a cancer patient during treatment or at the end of life, the public focus on CAM and cancer has created a driving force for cancer centers to address the efficacy and science of these methods.

Currently, the majority of cancer patients do not receive adequate palliative care. Acupuncture has been shown to be effective in the treatment of pain and nausea and has also been shown to improve one's general well-being. Acupuncture also has some effectiveness in relieving symptoms of anxiety and depression. This study will evaluate the efficacy of acupuncture by Traditional Chinese Medicine clinicians to address the quality of life and symptoms of patients with incurable cancer.

Women with recurrent metastatic ovarian cancer and similar patients with advanced cancer who are ambulatory and receiving conventional palliative care will be enrolled in this study. Patients will continue to receive high-quality, conventional clinical interventions, including chemotherapy and pain and symptom reduction programs. Patients will also receive 8 weeks of acupuncture. Evaluation tools such as Satisfaction with Life Domains Scale for Cancer (SLDS-C), Brief Pain Inventory, and Rotterdam Symptom Check List will be used to assess the acupuncture intervention.

Interventional
Phase 2
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Ovarian Cancer
Procedure: Acupuncture
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
February 2005
Not Provided

Inclusion Criteria

  • Advanced cancer patients, primarily ovarian cancer patients
  • Undergoing palliative care treatment
  • Ambulatory
  • Symptomatic with pain, nausea, and/or an inadequate quality of life
  • Platelets > 25,000/mm3
  • ANC > 500 cells/mm3

Exclusion Criteria

  • Acupuncture treatment during the 6 months prior to study entry
  • History of bleeding disorder, such as hemophilia or von Willebrand disease
  • Acute psychosis
Female
21 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00070967
R21 AT001010-01
Not Provided
Not Provided
National Center for Complementary and Alternative Medicine (NCCAM)
Not Provided
Principal Investigator: David S. Rosenthal, MD Dana-Farber Cancer Institute
National Center for Complementary and Alternative Medicine (NCCAM)
July 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP